Vascular Biogenics Ltd (VBLT)

[gr8db8]

Regarding NASH, the CEO indicated that they want a partner and don't want to pursue it alone ... because they are an oncology company .. but this comment in the prior Q1, and the lack of a partnership announcement all year, makes me wonder if 1) they didn't find a win-win type partnership and because of this 2) they will use the funding to move these NASH candidates forward.

==========
we're working on the second stage of the disease when it move to inflammation, because 201 is a Phase-2-ready drug, we believe that the data that we show in the preclinical is as good as many of the compounds that went into a Phase 2 and there would be someone that will want to develop it, but they want to make it very clear that we are focused on oncology, we have lot on the plate and we are not going to do this trial by ourselves
==========